These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8210705)

  • 21. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
    Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.
    Tsen YJ; Chang MH; Hsu HY; Lee CY; Sung JL; Chen DS
    J Med Virol; 1991 Jun; 34(2):96-9. PubMed ID: 1832440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A.
    Lancet; 1979 Feb; 1(8113):433-4. PubMed ID: 84277
    [No Abstract]   [Full Text] [Related]  

  • 26. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy.
    Mele A; Tancredi F; Romanò L; Giuseppone A; Colucci M; Sangiuolo A; Lecce R; Adamo B; Tosti ME; Taliani G; Zanetti AR
    J Infect Dis; 2001 Oct; 184(7):905-8. PubMed ID: 11509998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY; Sung JL
    J Med Virol; 1986 Apr; 18(4):301-7. PubMed ID: 2940332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.
    Oon CJ; Chen WN; Goh KT; Mesenas S; Ng HS; Chiang G; Tan C; Koh S; Teng SW; Toh I; Moh MC; Goo KS; Tan K; Leong AL; Tan GS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S491-6. PubMed ID: 12534784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of methods of pre-vaccination screening for markers of hepatitis B infection.
    Papaevangelou G; Roumeliotou-Karayannis A; Tassopoulos N; Richardson SC; Stathopoulou P; Papadoyannakis N; Tsantoulis N; Politi K; Tassiopoulou A
    Eur J Epidemiol; 1985 Jun; 1(2):100-3. PubMed ID: 2946600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

  • 32. Rationale for the infant and adolescent vaccination programmes in Italy.
    Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S31-4. PubMed ID: 10683541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vaccination against hepatitis B: success and challenges].
    Michel ML
    Med Sci (Paris); 2016 8-9; 32(8-9):739-45. PubMed ID: 27615182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.
    Whittle HC; Inskip H; Hall AJ; Mendy M; Downes R; Hoare S
    Lancet; 1991 Mar; 337(8744):747-50. PubMed ID: 1672389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of hepatitis B virus infection in Third-World countries.
    Prince AM
    Transfus Med Rev; 1990 Jul; 4(3):187-90. PubMed ID: 1966884
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevalence of hepatitis B and D serological markers in the Parakanã, Apyterewa Indian Reservation, Pará State, Brazil].
    Nunes HM; Monteiro MR; Soares Mdo C
    Cad Saude Publica; 2007 Nov; 23(11):2756-66. PubMed ID: 17952269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.
    Sulaiman HA
    Gastroenterol Jpn; 1989 Aug; 24(4):434-41. PubMed ID: 2550307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.